Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSL-001 transbuccal insulin film versus subcutaneous Humulin R in adults with type 1 diabetes mellitus
ACTRN12615000495527Phase 2Completed
- Sponsor
- Biodexa Pharmaceuticals
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of Midaform insulin and human insulin in diabetes mellitus type 1 (T1D) (8 arms), sponsored by Biodexa Pharmaceuticals. Primary endpoint: Pharmacodynamic profile by glucose infusion rate. Started Jul 2015; status: completed.
02
Drugs
Midaform insulinhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ACTRN12615000495527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000495527.